ABSTRACT
Abstract Introduction: Pelvic floor muscle training (PFMT) and neuromuscular electrical stimulation (NMES) are physiotherapeutic conservative treatments to prevent and to treat pelvic floor dysfunctions. Objective: To investigate the immediate effect of one session of PFMT versus NMES associated to pelvic floor muscle (PFM) contraction on the PFM function in nulliparous women. Methods: This is a cross-sectional experimental study. Twenty women were randomized into the "PFMT Group" and "NMES Group". PFM function evaluation was performed by vaginal palpation and manometry before and after a single session. PFMT was composed by one series of eight sustained contractions of 6 seconds and one series of four fast contractions, in four different positions. NMES parameters were: biphasic pulsed current; frequency: 50 Hz; pulse duration: 0.7 ms; cycle on:off 4:8s; rise/decay: 2/2s, time: 20 minutes; and intensity: participant' sensibility. Data was analyzed by the ANOVA two-way for repeated measures to verify the difference between groups, within group and the interactions for PFM function. A 5% probability was considered in all tests. Results: There were no significant differences between groups. At intra-group analysis, there was a significant decrease in the maximal voluntary contraction (p = 0.01), by manometry, between pre- and post-session for both groups. Conclusion: The immediate effects of a single session of PFMT and NMES associated with voluntary PFM contraction are similar on PFM function, that is, no difference was found between groups.
Resumo Introdução: O treinamento dos músculos do assoalho pélvico (TMAP) e estimulação elétrica neuromuscular (EENM) são recursos fisioterapêuticos utilizados para prevenir e reabilitar de forma conservadora as disfunções do assoalho pélvico. Objetivo: Investigar o efeito imediato de uma sessão de TMAP versus EENM associada à contração dos músculos do assoalho pélvico (MAP) sobre a função dos MAP em mulheres nulíparas. Métodos: Estudo experimental transversal. Vinte mulheres foram randomizadas em "Grupo TMAP" e "Grupo EENM". A avaliação da função dos MAP foi realizada por palpação vaginal e manometria, antes e após uma única sessão. O TMAP foi composto por uma série de oito contrações sustentadas de 6 segundos e uma série de quatro contrações rápidas, em quatro posições diferentes. Os parâmetros de EENM foram: corrente bifásica pulsada; frequência: 50 Hz; duração do pulso: 0,7 ms; ciclo on:off 4:8s; subida/descida: 2/2s; tempo: 20 minutos; e intensidade: sensibilidade da participante. O teste de ANOVA two-way para medidas repetidas foi aplicado para verificar a diferença intra e entre grupos e as interações para as variáveis da função dos MAP. Considerou-se nível de significância de 5% em todos os testes. Resultados: Não houve diferenças significativas na comparação entre grupos. Na análise intragrupo houve diminuição significativa da variável contração voluntária máxima (p = 0,01), por manometria, entre pré e pós-sessão para ambos os grupos. Conclusão: Os efeitos imediatos de uma única sessão de TMAP e EENM associados à contração voluntária dos MAP são semelhantes na função dos MAP, ou seja, nenhuma diferença foi observada entre os grupos.
ABSTRACT
Objective To summarize the clinical efficacy of Endu combined with intrapleural injection of cisplatin in the treatment of malignant pleural effusion of non-small cell lung cancer.Methods80 patients with malignant pleural effusion were selected from January 2014 to December 2015.The patients were randomly divided into observation group and control group (n=40).The control group was given Endu(40mg/time, 1 time/week) combined with cisplatin (40mg/time, 1 time/week) intraperitoneal injection treatment, the treatment group was given Endu intraperitoneal injection therapy, After 4 weeks of treatment, the clinical efficacy and adverse reactions were observed.ResultsThe clinical efficacy of the observation group was significantly higher than that of the control group (50.00%).The difference was statistically significant (P<0.05).The incidence of adverse reactions in the observation group was 15.00% higher than that in the control group, but the difference was not significant.The improvement rate of life quality in the observation group was significantly higher than that in the control group (52.50%).The difference between the two groups was statistically significant (P<0.05).ConclusionThe clinical efficacy of Endu combined with intrapleural injection of cisplatin in the treatment of malignant pleural effusion of non-small cell lung cancer is superior to that of simple analgesia, which can significantly improve the clinical symptoms and quality of life.It is worthy to be popularized in clinical practice.